Viewing Study NCT01251861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:25 PM
Ignite Modification Date: 2026-01-31 @ 7:27 AM
Study NCT ID: NCT01251861
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-11
First Post: 2010-12-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Prostate Carcinoma View
None Stage I Prostate Cancer AJCC v7 View
None Stage IIA Prostate Cancer AJCC v7 View
None Stage IIB Prostate Cancer AJCC v7 View
None Stage III Prostate Cancer AJCC v7 View
Keywords: